OptimizeRx Corp (OPRX) › RevenueOptimizeRx Corp (OPRX) — RevenueAnnual figures by period end, from SEC filings.2010-12-31: $71.1K2011-12-31: $1.11M2012-12-31: $1.99M2013-12-31: $4.68M2014-12-31: $6.50M2015-12-31: $7.22M2016-12-31: $7.75M2017-12-31: $12.13M2018-12-31: $21.21M2019-12-31: $24.60M2020-12-31: $43.31M2021-12-31: $61.29M2022-12-31: $62.45M2023-12-31: $71.52M2024-12-31: $92.13M2025-12-31: $109.43M$109.43M2010-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$109.43M+18.8%2026-03-12From 2025-01-012024-12-31$92.13M+28.8%2026-03-12From 2024-01-012023-12-31$71.52M+14.5%2025-03-20From 2023-01-012022-12-31$62.45M+1.9%2024-04-15From 2022-01-012021-12-31$61.29M+41.5%2023-03-10From 2021-01-012020-12-31$43.31M+76.1%2023-03-10From 2020-01-012019-12-31$24.60M+16.0%2021-03-08From 2019-01-012018-12-31$21.21M+74.9%2020-03-26From 2018-01-012017-12-31$12.13M+56.5%2019-03-12From 2017-01-012016-12-31$7.75M+7.4%2018-03-08From 2016-01-012015-12-31$7.22M+11.0%2017-03-08From 2015-01-012014-12-31$6.50M+39.0%2016-03-15From 2014-01-012013-12-31$4.68M+135.3%2015-09-16From 2013-01-012012-12-31$1.99M+79.0%2014-03-31From 2012-01-012011-12-31$1.11M+1464.1%2013-03-12From 2011-01-012010-12-31$71.1K—2012-03-30From 2010-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)